Found 7 hits for monomerid = 50393538 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Macrophage colony stimulating factor receptor
(Homo sapiens (Human)) | BDBM50393538
(CHEMBL2158224)Show SMILES O=C(Nc1ccc(cc1C1=CCCCC1)C1CCN(Cc2ccccn2)CC1)c1ncc([nH]1)C#N |t:10| Show InChI InChI=1S/C28H30N6O/c29-17-24-18-31-27(32-24)28(35)33-26-10-9-22(16-25(26)21-6-2-1-3-7-21)20-11-14-34(15-12-20)19-23-8-4-5-13-30-23/h4-6,8-10,13,16,18,20H,1-3,7,11-12,14-15,19H2,(H,31,32)(H,33,35) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Inhibition of FMS mediated phosphorylation using SYEGNSYTFIDPTQ as substrate after 80 mins by fluorescence polarization |
J Med Chem 54: 7860-83 (2011)
Article DOI: 10.1021/jm200900q BindingDB Entry DOI: 10.7270/Q2VD70JB |
More data for this Ligand-Target Pair | |
Macrophage colony-stimulating factor 1 receptor (c-Fms)
(Mus musculus (Mouse)) | BDBM50393538
(CHEMBL2158224)Show SMILES O=C(Nc1ccc(cc1C1=CCCCC1)C1CCN(Cc2ccccn2)CC1)c1ncc([nH]1)C#N |t:10| Show InChI InChI=1S/C28H30N6O/c29-17-24-18-31-27(32-24)28(35)33-26-10-9-22(16-25(26)21-6-2-1-3-7-21)20-11-14-34(15-12-20)19-23-8-4-5-13-30-23/h4-6,8-10,13,16,18,20H,1-3,7,11-12,14-15,19H2,(H,31,32)(H,33,35) | PDB MMDB
KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Inhibition of FMS-mediated proliferation in CSF1-stimulated bone marrow-derived mouse macrophages assessed as inhibition of incorporation of bromodeo... |
J Med Chem 54: 7860-83 (2011)
Article DOI: 10.1021/jm200900q BindingDB Entry DOI: 10.7270/Q2VD70JB |
More data for this Ligand-Target Pair | |
Cytochrome P450 1A
(Homo sapiens (Human)) | BDBM50393538
(CHEMBL2158224)Show SMILES O=C(Nc1ccc(cc1C1=CCCCC1)C1CCN(Cc2ccccn2)CC1)c1ncc([nH]1)C#N |t:10| Show InChI InChI=1S/C28H30N6O/c29-17-24-18-31-27(32-24)28(35)33-26-10-9-22(16-25(26)21-6-2-1-3-7-21)20-11-14-34(15-12-20)19-23-8-4-5-13-30-23/h4-6,8-10,13,16,18,20H,1-3,7,11-12,14-15,19H2,(H,31,32)(H,33,35) | PDB MMDB
Reactome pathway KEGG
B.MOAD DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Inhibition of CYP1A2 |
J Med Chem 54: 7860-83 (2011)
Article DOI: 10.1021/jm200900q BindingDB Entry DOI: 10.7270/Q2VD70JB |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50393538
(CHEMBL2158224)Show SMILES O=C(Nc1ccc(cc1C1=CCCCC1)C1CCN(Cc2ccccn2)CC1)c1ncc([nH]1)C#N |t:10| Show InChI InChI=1S/C28H30N6O/c29-17-24-18-31-27(32-24)28(35)33-26-10-9-22(16-25(26)21-6-2-1-3-7-21)20-11-14-34(15-12-20)19-23-8-4-5-13-30-23/h4-6,8-10,13,16,18,20H,1-3,7,11-12,14-15,19H2,(H,31,32)(H,33,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Displacement of [3H]astemizole from human ERG potassium channel |
J Med Chem 54: 7860-83 (2011)
Article DOI: 10.1021/jm200900q BindingDB Entry DOI: 10.7270/Q2VD70JB |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50393538
(CHEMBL2158224)Show SMILES O=C(Nc1ccc(cc1C1=CCCCC1)C1CCN(Cc2ccccn2)CC1)c1ncc([nH]1)C#N |t:10| Show InChI InChI=1S/C28H30N6O/c29-17-24-18-31-27(32-24)28(35)33-26-10-9-22(16-25(26)21-6-2-1-3-7-21)20-11-14-34(15-12-20)19-23-8-4-5-13-30-23/h4-6,8-10,13,16,18,20H,1-3,7,11-12,14-15,19H2,(H,31,32)(H,33,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Inhibition of CYP2C19 |
J Med Chem 54: 7860-83 (2011)
Article DOI: 10.1021/jm200900q BindingDB Entry DOI: 10.7270/Q2VD70JB |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50393538
(CHEMBL2158224)Show SMILES O=C(Nc1ccc(cc1C1=CCCCC1)C1CCN(Cc2ccccn2)CC1)c1ncc([nH]1)C#N |t:10| Show InChI InChI=1S/C28H30N6O/c29-17-24-18-31-27(32-24)28(35)33-26-10-9-22(16-25(26)21-6-2-1-3-7-21)20-11-14-34(15-12-20)19-23-8-4-5-13-30-23/h4-6,8-10,13,16,18,20H,1-3,7,11-12,14-15,19H2,(H,31,32)(H,33,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Inhibition of CYP3A4 |
J Med Chem 54: 7860-83 (2011)
Article DOI: 10.1021/jm200900q BindingDB Entry DOI: 10.7270/Q2VD70JB |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50393538
(CHEMBL2158224)Show SMILES O=C(Nc1ccc(cc1C1=CCCCC1)C1CCN(Cc2ccccn2)CC1)c1ncc([nH]1)C#N |t:10| Show InChI InChI=1S/C28H30N6O/c29-17-24-18-31-27(32-24)28(35)33-26-10-9-22(16-25(26)21-6-2-1-3-7-21)20-11-14-34(15-12-20)19-23-8-4-5-13-30-23/h4-6,8-10,13,16,18,20H,1-3,7,11-12,14-15,19H2,(H,31,32)(H,33,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Inhibition of CYP2C9 |
J Med Chem 54: 7860-83 (2011)
Article DOI: 10.1021/jm200900q BindingDB Entry DOI: 10.7270/Q2VD70JB |
More data for this Ligand-Target Pair | |